Skip to content
Trial Eligibility
Menu

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

NCT06959277

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report better awareness of their foot placement on the ground. Researchers will compare Walkasins users to a control group of participants who are not using Walkasins to see if the device improves the users' performance on some standing and walking tests.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Peripheral Neuropathies
  • Peripheral Neuropathy Due to Chemotherapy
  • Peripheral Neuropathy With Type 2 Diabetes
  • Balance Control in Elderly
  • Gait Disorders

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
55 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
RxFunction Inc.
Last updated on ClinicalTrials.gov
October 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 1

  • Fairview Frontiers · Saint Paul, MN

New York · 1

  • Dent Neurologic Institute · Amherst, NY

Pennsylvania · 1

  • University of Pittsburgh · Pittsburgh, PA

Texas · 1

  • University of Texas Medical Branch · Galveston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.